2026 Q1 Portfolio Activity
In 2026 Q1, Eversept Partners, LP maintained a portfolio of 151 distinct positions. The most significant new addition was VERTEX PHARMACEUTICALS INC, now representing 2.12% of the total fund value. They heavily accumulated shares in BROOKDALE SR LIVING INC, increasing the position by 851.8%. The fund also reduced its exposure to VERA THERAPEUTICS INC by 29.3%.
Position History
hover any row below to update
Loading…
Total Positions
151
Quarter
2026 Q1
Top Holding
UTHR (8.3%)
Top 10 Concentration
47.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 151
Eversept Partners, LP Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
UTHR
UNITED THERAPEU...
|
Healthcare | 8.26% | 6.20% |
#1
3
Prev: #4
|
5.8 | 11,679 | 4.6% |
P
S
|
264,271 | $156,707,418 | 2020 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
QQQ
PUT
INVESCO QQQ TR
|
PUT Option | 7.26% | 6.97% |
#2
Prev: #2
|
6.4 | 13,700 | 6.1% |
P
S
|
238,700 | $137,772,866 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 5.49% | 4.47% |
#3
2
Prev: #5
|
5.7 | 276,589 | 42.0% |
P
S
|
934,423 | $104,048,001 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GSK
GSK PLC
|
Healthcare | 5.20% | 6.62% |
#4
1
Prev: #3
|
2.6 | -894,546 | -33.4% |
P
S
|
1,785,175 | $98,523,808 | 2018 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 4.61% | 7.84% |
#5
4
Prev: #1
|
2.3 | -899,018 | -29.3% |
P
S
|
2,173,286 | $87,431,296 | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NTRA
NATERA INC
|
Healthcare | 4.06% | 3.86% |
#6
Prev: #6
|
3.6 | 50,220 | 15.0% |
P
S
|
384,713 | $76,938,753 | 2018 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SPY
PUT
STATE STR SPDR ...
|
PUT Option | 3.67% | 1.54% |
#7
10
Prev: #17
|
4.5 | 62,100 | 138.3% |
P
S
|
107,000 | $69,586,380 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 3.55% | 3.51% |
#8
1
Prev: #7
|
1.9 | -428,786 | -12.9% |
P
S
|
2,885,622 | $67,408,130 | 2022 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 2.99% | 1.96% |
#9
5
Prev: #14
|
3.7 | 353,291 | 24.6% |
P
S
|
1,788,016 | $56,715,868 | 2020 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 2.83% | 2.78% |
#10
1
Prev: #9
|
1.1 | -273,529 | -22.8% |
P
S
|
924,193 | $53,704,855 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BKD
BROOKDALE SR LI...
|
Healthcare | 2.57% | 0.20% |
#11
65
Prev: #76
|
4.0 | 3,193,626 | 851.8% |
P
S
|
3,568,555 | $48,817,832 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 2.50% | 2.15% |
#12
1
Prev: #13
|
3.0 | 93,882 | 17.4% |
P
S
|
632,100 | $47,464,389 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VRTX
CALL
VERTEX PHARMACE...
|
CALL Option | 2.12% | — |
#13
Prev: #—
|
4.3 | 90,000 | — |
NEW
|
90,000 | $40,188,600 | 2018 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HCA
HCA HEALTHCARE ...
|
Healthcare | 1.98% | 2.26% |
#14
3
Prev: #11
|
1.3 | -16,645 | -17.4% |
P
S
|
79,229 | $37,494,332 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TLT
PUT
ISHARES TR
|
PUT Option | 1.96% | 1.01% |
#15
13
Prev: #28
|
3.8 | 198,800 | 86.4% |
P
S
|
428,800 | $37,172,672 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
WELL
WELLTOWER INC
|
Real Estate | 1.89% | — |
#16
Prev: #—
|
4.3 | 180,953 | — |
NEW
|
180,953 | $35,776,218 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DOC
HEALTHPEAK PROP...
|
Real Estate | 1.72% | — |
#17
Prev: #—
|
4.2 | 1,981,070 | — |
NEW
|
1,981,070 | $32,548,980 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PODD
INSULET CORP
|
Healthcare | 1.59% | 1.07% |
#18
6
Prev: #24
|
3.6 | 68,838 | 92.1% |
P
S
|
143,546 | $30,121,693 | 2018 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 1.53% | 1.18% |
#19
1
Prev: #20
|
1.1 | 46,925 | 1.6% |
P
S
|
3,039,820 | $28,939,086 | 2017 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GERN
GERON CORP
|
Healthcare | 1.48% | 1.17% |
#20
1
Prev: #21
|
2.6 | 1,174,900 | 6.7% |
P
S
|
18,834,883 | $28,063,976 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
OHI
OMEGA HEALTHCAR...
|
Real Estate | 1.35% | — |
#21
Prev: #—
|
4.0 | 585,680 | — |
NEW
|
585,680 | $25,664,498 | 2019 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LQDA
LIQUIDIA CORPOR...
|
Healthcare | 1.35% | 0.89% |
#22
7
Prev: #29
|
3.0 | 167,949 | 33.0% |
P
S
|
677,392 | $25,564,774 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CYH
COMMUNITY HEALT...
|
Healthcare | 1.35% | 1.25% |
#23
5
Prev: #18
|
2.5 | 733,479 | 9.2% |
P
S
|
8,677,281 | $25,511,206 | 2019 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVTR
AVANTOR INC
|
Healthcare | 1.23% | 1.83% |
#24
8
Prev: #16
|
1.0 | -202,357 | -6.4% |
P
S
|
2,974,287 | $23,318,410 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
QIAGEN NV
|
|
Unknown | 1.15% | — |
#25
Prev: #—
|
4.0 | 545,330 | — |
NEW
|
545,330 | $21,835,013 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
N/A
CALL
QIAGEN NV
|
|
CALL Option | 1.01% | — |
#26
Prev: #—
|
3.9 | 476,300 | — |
NEW
|
476,300 | $19,071,052 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
EHC
ENCOMPASS HEALT...
|
Healthcare | 0.99% | 0.57% |
#27
19
Prev: #46
|
3.4 | 87,178 | 81.5% |
P
S
|
194,104 | $18,775,680 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 0.92% | 0.58% |
#28
17
Prev: #45
|
3.4 | 8,377 | 78.9% |
P
S
|
19,000 | $17,475,630 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 0.85% | 2.26% |
#29
19
Prev: #10
|
0.3 | -632,358 | -53.8% |
P
S
|
542,610 | $16,120,943 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INSM
CALL
INSMED INC
|
CALL Option | 0.81% | — |
#30
Prev: #—
|
3.8 | 94,000 | — |
NEW
|
94,000 | $15,370,880 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.79% | 0.54% |
#31
16
Prev: #47
|
2.8 | 681,424 | 27.2% |
P
S
|
3,188,514 | $14,986,016 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HYG
PUT
ISHARES TR
|
PUT Option | 0.76% | — |
#32
Prev: #—
|
3.8 | 180,000 | — |
NEW
|
180,000 | $14,320,800 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RGEN
REPLIGEN CORP
|
Healthcare | 0.75% | — |
#33
Prev: #—
|
3.8 | 120,785 | — |
NEW
|
120,785 | $14,230,889 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BBNX
BETA BIONICS IN...
|
Healthcare | 0.75% | 1.04% |
#34
9
Prev: #25
|
3.3 | 736,576 | 108.6% |
P
S
|
1,414,838 | $14,176,677 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.74% | 2.79% |
#35
27
Prev: #8
|
0.3 | -1,068,966 | -60.0% |
P
S
|
713,269 | $13,951,542 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 0.72% | 0.64% |
#36
6
Prev: #42
|
2.8 | 141,946 | 32.7% |
P
S
|
576,580 | $13,584,225 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ARDX
ARDELYX INC
|
Healthcare | 0.70% | 0.50% |
#37
17
Prev: #54
|
2.8 | 514,317 | 30.0% |
P
S
|
2,229,446 | $13,354,382 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LTC
LTC PPTYS INC
|
Real Estate | 0.63% | — |
#38
Prev: #—
|
3.8 | 321,046 | — |
NEW
|
321,046 | $11,930,069 | 2019 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 0.62% | 0.28% |
#39
28
Prev: #67
|
3.2 | 114,020 | 121.6% |
P
S
|
207,768 | $11,736,814 | 2017 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CHE
CHEMED CORP NEW
|
Healthcare | 0.62% | — |
#40
Prev: #—
|
3.7 | 31,057 | — |
NEW
|
31,057 | $11,731,471 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 0.61% | 0.61% |
#41
2
Prev: #43
|
0.7 | -32,217 | -7.3% |
P
S
|
406,960 | $11,496,620 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UNH
CALL
UNITEDHEALTH GR...
|
CALL Option | 0.57% | — |
#42
Prev: #—
|
3.7 | 40,000 | — |
NEW
|
40,000 | $10,823,600 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IWM
PUT
ISHARES TR
|
PUT Option | 0.52% | — |
#43
Prev: #—
|
3.7 | 40,000 | — |
NEW
|
40,000 | $9,920,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PNTG
PENNANT GROUP I...
|
Healthcare | 0.50% | 0.42% |
#44
16
Prev: #60
|
2.2 | 18,218 | 6.2% |
P
S
|
312,178 | $9,515,185 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XLK
PUT
SELECT SECTOR S...
|
PUT Option | 0.49% | — |
#45
Prev: #—
|
3.7 | 70,000 | — |
NEW
|
70,000 | $9,303,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 0.48% | 0.74% |
#46
12
Prev: #34
|
0.2 | -135,063 | -32.1% |
P
S
|
285,764 | $9,147,306 | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 0.46% | 0.64% |
#47
6
Prev: #41
|
0.7 | -404,049 | -7.5% |
P
S
|
4,987,499 | $8,728,123 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MRNA
MODERNA INC
|
Healthcare | 0.43% | 0.40% |
#48
13
Prev: #61
|
0.2 | -108,115 | -40.4% |
P
S
|
159,708 | $8,113,166 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 0.41% | — |
#49
Prev: #—
|
3.7 | 239,110 | — |
NEW
|
239,110 | $7,780,639 | 2018 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ICLR
ICON PLC
|
Healthcare | 0.40% | 0.88% |
#50
20
Prev: #30
|
0.2 | -27,144 | -28.3% |
P
S
|
68,688 | $7,601,014 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 151 holdings